This document outlines details of PBS-subsidised avatrombopag, eltrombopag and romiplostim for patients with severe chronic immune (idiopathic) thrombocytopenic purpura (ITP).
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.
Idiopathic thrombocytopenic purpura (ITP) quick reference
Restrictions | Authority level and section | PA assessment | Processing system | Prescriber type | Prescriber self-serve |
Initial PB097 form | Written Electronic S100: avatrombopag eltrombopag romiplostim | No | OPA | Not specified | Yes |
First continuing or re-initiation of interrupted continuing treatment | Telephone Electronic S100: avatrombopag eltrombopag romiplostim | No | OPA | Not specified | Yes |
Second or subsequent continuing | Telephone Electronic S100: avatrombopag eltrombopag romiplostim | No | OPA | Not specified | Yes |
Balance of supply or change of therapy | Telephone Electronic S100: avatrombopag eltrombopag romiplostim | No | OPA | Not specified | Yes |
Expand all